Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Compare diversification outcomes of common stock index options in retirement planning, highlighting practical considerations.
25,636 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Northcoast downgraded Norwegian Cruise Line amid macro headwinds, signaling tougher times for the sector as Middle Ea...
AST SpaceMobile is set to unveil first-quarter results tonight. With a volatile backdrop and a slate of potential cat...
HSBC upgraded Cisco to Buy and lifted the price target as the company moves toward a $6 billion AI revenue goal for F...
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...
The surge in digital payments and online lending has unlocked fresh opportunities in fintech. This guide shows you ho...
As the 10-year treasury yield approaches 5%, SCHG faces higher discount rates that could compress growth valuations. ...
STRC dips to about $94.65, roughly 5% under its $100 par, renewing questions about Strategy's bitcoin strategy and th...
In a renewed push to accumulate, Strategy added 1,550 BTC for about $101 million in early June, boosting holdings to ...
A reported breakthrough on Iran negotiations sparked a risk-on market rally and shifted bets on the Federal Reserve's...
Forecasters warn the 2026 El Niño could be one of the strongest on record, risking broad economic shocks and volatile...
Global equities tumble as Federal Reserve signals higher rates for longer, triggering a broad selloff across risk ass...